+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-24Number of Pages: 176

Platelet Rich Plasma (PRP) Market (Type - Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Plasma (L-PRP), and Pure-Platelet-Rich Fibrin (P-PRF); Origin - Autologous, Homologous, and Allogeneic; Application - Orthopedic Surgery, Neurosurgery, Cosmetic Surgery, General Surgery, Urological Surgery, Cardiothoracic Surgery, and Periodontal Surgery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Platelet Rich Plasma (PRP) Market: Snapshot

In the last few years, the global platelet rich plasma (PRP) market has witnessed significant growth in its valuation. This growth is ascribable to the increasing incidence of orthopedic diseases, propelled by the rising cases of sports injuries and the rising prevalence of neurological and cardiothoracic disorders. Besides this, the market is gaining from the overall surge in cosmetic surgeries witnessed around the world. As people begin realizing the benefits of platelet rich plasma, it is likely its demand to spike.

According to Transparency Market Research (TMR), the global platelet rick plasma (PRP) market is expected to reach US$451.9 mn by the end of 2024, from a valuation of US$160.0 mn in 2015. If these figures hold true the market will exhibit a CAGR of 12.50% between 2016 and 2024.

P-PRP Segment to Remain Dominant, but P-PRF Segment to Exhibit Higher CAGR

Leukocyte-platelet rich plasma (L-PRP), pure-platelet-rich fibrin (P-PRF), and pure-platelet rich plasma (P-PRP) constitute the key market segments based on product. Of these, due to higher consumption, P-PRP will enjoy dominance in the global market. In 2015, the segment registered its lead with a share of 2015. P-PRP has richer content of platelets compared to the conventional variants of PRP, which is the key factor aiding its growth.

While P-PRP segment is expected to remain dominant over the next few years, it is the P-PRF segment, which is expected record a higher CAGR during the course of the forecast period. P-PRF exhibits higher efficiency and the presence of a large number of leukocytes and stem cells. This is anticipated to bolster demand from the segment significant in the near future.

rich plasma market

North America to Remain Dominant Regional PRP Market through Forecast Period

Regionally, the global platelet rich plasma market can be segmented into Asia Pacific, Europe, Latin America, the Middle East and Africa, and North America. Among these regions, North America emerged dominant in 2015 with a share of 45% in the global platelet rich plasma market. The increasing incidence of orthopedic diseases and sports injuries, coupled with the availability of improved diagnostics and advanced healthcare facilities augmented the demand for PRP from North America. Going forward, the high uptake of PRP products will seal North America’s dominance in the global market over the forecast period.

In 2015, Europe emerged as the second-leading market for platelet rich plasma and is also expected to retain its position during the forecast period. The rising demand for cosmetic procedures across the leading economies will aid the expansion of PRP market in Europe. Besides this, the market players will also have a highly lucrative market in Asia Pacific. The growth witnessed by the PRP market in Asia Pacific will be at a phenomenal pace due to the rising geriatric population and the increasing demand for latest cosmetic surgeries in the region.

At the forefront of the global platelet rich plasma market, companies such as Nuo Therapeutics, Regen Lab SA, DePuy Synthes Inc., ISTO Biologics, Regen Lab SA, Emcyte Corp., Arthrex Inc., AdiStem Ltd., Zimmer Biomet, Exactech Inc., Cesca Therapeutics Inc Stryker Corp., and Harvest Technologies Corp will register their prominence.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Platelet Rich Plasma: Market Snapshot
3.2 Global Market Share Analysis by Region, 2015
3.3 Global Platelet-Rich Plasma Market: Opportunity Map

Section 4 Market Overview
4.1 Product Overview
4.2 Global Platelet-Rich Plasma Market: Key Industry Developments
4.3 Global Platelet-Rich Plasma Market: Market Indicators

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Increasing incidence of orthopedic and sports injuries
      5.2.2 Rising number of cosmetic surgical procedures
      5.2.3 Technological advancements and regulatory approvals for new devices
      5.2.4 Increasing popularity of PRP products and treatments
      5.2.5 Growing awareness about Platelet-Rich Plasma therapies
5.3 Restraints
      5.3.1 Standardization in quality of allergen extracts
      5.3.2 Difficulty in quality control of test results
5.4 Opportunities
      5.4.1 Ultrasound & Platelet Rich Plasma Therapy
      5.4.2 Advances in Technology & Devices will open new avenues
5.5 Porters Analysis
5.6 Value Chain Analysis 
5.7 Platelet-Rich Plasma Market Outlook

Section 6 Platelet-Rich Plasma Market Analysis, by Type 
6.1 Key Findings
6.2 Introduction
6.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Type 
6.4 Platelet-Rich Plasma Market Forecast, by Type 
6.5 Platelet-Rich Plasma Market Analysis, by Type 
      6.5.1 Pure-PRP
      6.5.2 Leukocyte-rich-PRP
      6.5.3 Pure-PRF
6.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Type 
6.7 Key Trends

Section 7 Platelet-Rich Plasma Market Analysis, by Origin
7.1 Key Findings
7.2 Introduction
7.4 Platelet-Rich Plasma Market Forecast, by Origin
7.5 Platelet-Rich Plasma Market Analysis, by Origin
      7.5.1 Autologous PRP
      7.5.2 Allogeneic PRP
      7.5.3 Homologous PRP
7.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Origin
7.7 Key Trends

Section 8 Platelet-Rich Plasma Market Analysis, by Applications 
8.1 Key Findings
8.2 Introduction
8.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Applications 
8.4 Platelet-Rich Plasma Market Forecast, by Applications 
8.5 Platelet-Rich Plasma Market Analysis, by Applications 
      8.5.1 Orthopedic Surgery
      8.5.2 Cosmetic Surgery
      8.5.3 General Surgery 
      8.5.4 Neurosurgery
      8.5.5 Others
8.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Applications 

Section 9 Platelet-Rich Plasma Market Analysis, by Region
9.1 Global Platelet-Rich Plasma Market Snapshot, by Country
9.2 Global Platelet-Rich Plasma Market Value Share Analysis, by Region
9.3 Platelet-Rich Plasma Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Platelet-Rich Plasma Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, by Country
      10.3.1 North America Market Value Share Analysis, by Country
      10.3.2 North America Market Forecast by Country
10.4 Market Analysis, by Type
      10.4.1 North America Market Value Share Analysis, by Type 
      10.4.2 North America Market Forecast, by Type 
10.5 Market Analysis, by Origin 
      10.5.1 North America Market Value Share Analysis, by Origin 
      10.5.2 North America Market Forecast, by Origin 
10.6 Market Analysis, by Applications
      10.6.1 North America Market Value Share Analysis, by Applications 
      10.6.2 North America Market Forecast, by Applications 
10.7 North America Market Attractiveness Analysis
      10.7.1 By Type
      10.7.2 By Origin 
      10.7.3 By Applications
10.8 Market Trends

Section 11 Europe Platelet-Rich Plasma Market Analysis
11.1 Key Findings 
11.2 Market Overview
11.3 Market Analysis, by Country
      11.3.1 Europe Market Value Share Analysis, by Country
      11.3.2 Europe Market Forecast by Country
11.4 Market Analysis, by Type
      11.4.1 Europe Market Value Share Analysis, by Type 
      11.4.2 Europe Market Forecast, by Type 
11.5 Market Analysis, by Origin 
      11.5.1 Europe Market Value Share Analysis, by Origin 
      11.5.2 Europe Market Forecast, by Origin 
11.6 Market Analysis, by Applications
      11.6.1 Europe Market Value Share Analysis, by Applications
      11.6.2 Europe Market Forecast, by Applications 
11.7 Europe Market Attractiveness Analysis
      11.7.1 By Type
      11.7.2 By Origin
      11.7.3 By Applications
11.8 Market Trends

Section 12 Asia Pacific Platelet-Rich Plasma Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, by Country
      12.3.1 Asia Pacific Market Value Share Analysis, by Country
      12.3.2 Asia Pacific Market Forecast by Country
12.4 Market Analysis, by Type
      12.4.1 Asia Pacific Market Value Share Analysis, by Type 
      12.4.2 Asia Pacific Market Forecast, by Type 
12.5 Market Analysis, by Origin 
      12.5.1 Asia Pacific Market Value Share Analysis, by Origin 
      12.5.2 Asia Pacific Market Forecast, by Origin 
12.6 Market Analysis, by Applications      
      12.6.1 Asia Pacific Market Value Share Analysis, by Applications 
      12.6.2 Asia Pacific Market Forecast, by Applications 
12.7 Asia Pacific Market Attractiveness Analysis
      12.7.1 By Type
      12.7.2 By Origin 
      12.7.3 By Applications
12.8 Market Trends

Section 13 Latin America Platelet-Rich Plasma Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, by Country
      13.3.1 Latin America Market Value Share Analysis, by Country
      13.3.2 Latin America Market Forecast by Country
13.4 Market Analysis, by Type
      13.4.1 Latin America Market Value Share Analysis, by Type 
      13.4.2 Latin America Market Forecast, by Type 
13.5 Market Analysis, by Origin 
      13.5.1 Latin America Market Value Share Analysis, by Origin 
      13.5.2 Latin America Market Forecast, by Origin 
13.6 Market Analysis, by Applications
      13.6.1 Latin America Market Value Share Analysis, by Applications
      13.6.2 Latin America Market Forecast, by Applications 
13.7 Latin America Market Attractiveness Analysis
      13.7.1 By Type
      13.7.2 By Origin 
      13.7.3 By Applications
13.8 Market Trends

Section 14 MEA Platelet-Rich Plasma Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, by Country
      14.3.1 MEA Market Value Share Analysis, by Country
      14.3.2 MEA Market Forecast by Country 
14.4 Market Analysis, by Type
      14.4.1 MEA Market Value Share Analysis, by Type 
      14.4.2 MEA Market Forecast, by Type 
14.5 Market Analysis, by Origin 
      14.5.1 MEA Market Value Share Analysis, by Origin 
      14.5.2 MEA Market Forecast, by Origin 
14.6 Market Analysis, by Applications
      14.6.1 MEA Market Value Share Analysis, by Applications
      14.6.2 MEA Market Forecast, by Applications 
14.7 MEA Market Attractiveness Analysis
      14.7.1 By Type
      14.7.2 By Origin 
      14.7.3 By Applications
14.8 Market Trends

Section 15 Company Profiles
15.1 Global Platelet-Rich Plasma Market Share Analysis, by Company (2015) 
15.2 Competition Matrix
15.3 Company Profiles
      15.3.1 Harvest Technologies Corporation
                15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.1.2 Financial Overview
                15.3.1.3 Product Portfolio
                15.3.1.4 SWOT Analysis
                15.3.1.5 Strategic Overview
      15.3.2 Arthrex, Inc.
                15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.2.2 Financial Overview
                15.3.2.3 Product Portfolio
                15.3.2.4 SWOT Analysis
                15.3.2.5 Strategic Overview
      15.3.3 Zimmer Biomet 
                15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.3.2 Financial Overview
                15.3.3.3 Product Portfolio
                15.3.3.4 SWOT Analysis
                15.3.3.5 Strategic Overview
      15.3.4 DePuy Synthes, Inc.
                15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.4.2 Financial Overview
                15.3.4.3 Product Portfolio
                15.3.4.4 SWOT Analysis
                15.3.4.5 Strategic Overview
      15.3.5 Stryker Corporation
                15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.5.2 Financial Overview
                15.3.5.3 Product Portfolio
                15.3.5.4 SWOT Analysis
                15.3.5.5 Strategic Overview
      15.3.6 AdiStem Ltd.
                15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.6.2 Financial Overview
                15.3.6.3 Product Portfolio
                15.3.6.4 SWOT Analysis
                15.3.6.5 Strategic Overview
      15.3.7 ISTO Biologics
                15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.7.2 Financial Overview
                15.3.7.3 Product Portfolio
                15.3.7.4 SWOT Analysis
                15.3.7.5 Strategic Overview
      15.3.8 Cesca Therapeutics, Inc.
                15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.8.2 Financial Overview
                15.3.8.3 Product Portfolio
                15.3.8.4 SWOT Analysis
                15.3.8.5 Strategic Overview
      15.3.9 Emcyte Corporation
                15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.9.2 Financial Overview
                15.3.9.3 Product Portfolio
                15.3.9.4 SWOT Analysis
                15.3.9.5 Strategic Overview
      15.3.10 Nuo Therapeutics
                15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.10.2 Financial Overview
                15.3.10.3 Product Portfolio
                15.3.10.4 SWOT Analysis
                15.3.10.5 Strategic Overview
      15.3.11 Exactech Inc.
                15.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.11.2 Financial Overview
                15.3.11.3 Product Portfolio
                15.3.11.4 SWOT Analysis
                15.3.11.5 Strategic Overview
      15.3.12 Regen Lab SA 
                15.3.12.1 Company Overview (HQ, Business Segments, Employee Strengths)
                15.3.12.2 Financial Overview
                15.3.12.3 Product Portfolio
                15.3.12.4 SWOT Analysis
                15.3.12.5 Strategic Overview

List of Figures

Figure 01: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global Platelet-Rich Plasma Market Value Share Analysis, by Type, 2016 and 2024
Figure 03: Global Pure Platelet-Rich Plasma Market Revenue (US$ Mn), 2014–2024
Figure 04: Global Leukocyte-Rich Platelet-Rich Plasma Market Revenue (US$ Mn), 2014–2024
Figure 05: Global Pure Platelet-Rich Fibrin Market Revenue (US$ Mn), 2014–2024
Figure 06: Platelet-Rich Plasma Market Attractiveness Analysis, by Type, 2016–2024
Figure 07: Global Platelet-Rich Plasma Market Value Share Analysis, by Origin, 2016 and 2024
Figure 08: Global Autologous Platelet-Rich Plasma Market Revenue (US$ Mn), 2014–2024
Figure 09: Global Allogeneic Platelet-Rich Plasma Market Revenue (US$ Mn), 2014–2024
Figure 10: Global Homologous Platelet-Rich Plasma Market Revenue (US$ Mn), 2014–2024
Figure 11: Platelet-Rich Plasma Market Attractiveness Analysis, by Origin, 2016–2024 
Figure 12: Global Platelet-Rich Plasma Market Value Share Analysis, by Application, 2016 and 2024
Figure 13: Global Orthopedic Surgery Market Revenue (US$ Mn), 2014–2024
Figure 14: Global Cosmetic Surgery Market Revenue (US$ Mn), 2014–2024
Figure 15: Global General Surgery Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Neurosurgery Market Revenue (US$ Mn), 2014–2024
Figure 17: Global Other Surgeries Market Revenue (US$ Mn), 2014–2024
Figure 18: Platelet-Rich Plasma Market Attractiveness Analysis, by Application, 2016–2024
Figure 19: Global Platelet-Rich Plasma Market Value Share Analysis, by Region, 2016 and 2024
Figure 20: Platelet-Rich Plasma Market Attractiveness Analysis, by Region, 2016–2024
Figure 21: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 22: North America Market Attractiveness Analysis, by Country, 2016–2024
Figure 23: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 24: North America Market Value Share Analysis, by Types, 2016 and 2024
Figure 25: North America Market Value Share Analysis by Origin 2016 and 2024
Figure 26: North America Market Value Share Analysis, by Applications, 2016 and 2024
Figure 27: North America Market Attractiveness Analysis, by Types, 2016-2024
Figure 28: North America Market Attractiveness Analysis, by Origin, 2016-2024
Figure 29: North America Market Attractiveness Analysis, by Applications, 2016-2024
Figure 30: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 31: Europe Market Attractiveness Analysis, by Country/ Region, 2016–2024
Figure 32: Europe Market Value Share Analysis, by Country/Region, 2016 and 2024
Figure 33: Europe Market Value Share Analysis, by Type, 2016 and 2024
Figure 34: Europe Market Value Share Analysis, by Origin, 2016 and 2024
Figure 35: Europe Market Value Share Analysis, by Application, 2016 and 2024
Figure 36: Europe Market Attractiveness Analysis, by Type, 2016–2024
Figure 37: Europe Market Attractiveness Analysis, by Origin 2016–2024
Figure 38: Europe Market Attractiveness Analysis, by Application, 2016–2024
Figure 39: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 40: Asia Pacific Market Attractiveness Analysis, by Country/Region, 2016–2024
Figure 41: Asia Pacific Market Value Share Analysis, by Country/ Region, 2016 and 2024
Figure 42: Asia Pacific Market Value Share Analysis, by Type, 2016 and 2024
Figure 43: Asia Pacific Market Value Share Analysis, by Origin, 2016 and 2024
Figure 44: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
Figure 45: Asia Pacific Market Attractiveness Analysis, by Type, 2016–2024
Figure 46: Asia Pacific Market Attractiveness Analysis, by Origin, 2016–2024
Figure 47: Asia Pacific Market Attractiveness Analysis, by Application, 2016–2024
Figure 48: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 49: Latin America Market Attractiveness Analysis, by Country,
Figure 50: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 51: Latin America Market Value Share Analysis, by Type, 2016 and 2024
Figure 52: Latin America Market Value Share Analysis, by Origin, 2016 and 2024
Figure 53: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 54: Latin America Market Attractiveness Analysis, by Type, 2016–2024
Figure 55: Latin America Market Attractiveness Analysis, by Origin, 2016–2024
Figure 56: Latin America Market Attractiveness Analysis, by Application, 2016–2024
Figure 57: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014–2024
Figure 58: MEA Market Attractiveness Analysis, by Country/ Region, 2016-2024
Figure 59: MEA Market Value Share Analysis, by Country, 2016 and 2024
Figure 60: MEA Market Value Share Analysis, by Types, 2016 and 2024
Figure 61: MEA Market Value Share Analysis, by Origin 2016 and 2024
Figure 62: MEA Market Value Share Analysis, by Applications, 2016 and 2024
Figure 63: MEA Market Attractiveness Analysis, by Types, 2016–2024
Figure 64: MEA Market Attractiveness Analysis, by Origin, 2016-2024
Figure 65: MEA Market Attractiveness Analysis, by Applications, 2016-2024
Figure 66: Global Platelet-Rich Plasma Market Share Analysis, by Company, (2015)

 

List of Tables

Table 01: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014–2024
Table 02: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 03: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 04: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 06: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Types, 2014–2024
Table 07: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 08: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Applications, 2014–2024
Table 09: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
Table 10: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014–2024
Table 11: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 12: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 13: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/ Region, 2014–2024
Table 14: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014–2024
Table 15: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 16: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 17: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 18: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014–2024
Table 19: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 20: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014–2024
Table 21: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country/ Region, 2014–2024
Table 22: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Types, 2014–2024
Table 23: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014–2024
Table 24: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Applications, 2014–2024

 

Global Platelet Rich Plasma (PRP) Market: Overview

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.

Global Platelet Rich Plasma (PRP) Market: Segmentation

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure-platelet-rich fibrin (P-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologous, homologous and allogeneic PRP.

Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2016 to 2024.

Global Platelet Rich Plasma (PRP) Market: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

It concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Global platelet rich plasma (PRP) market is segmented as follows:

By Type

  • Pure-Platelet Rich Plasma (P-PRP)
  • Leukocyte-Platelet Rich Plasma (L-PRP)
  • Pure-Platelet Rich Fibrin (P-PRF)

By Origin

  • Autologous
  • Homologous
  • Allogeneic

By Application

  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Other Surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial)

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa


 
 
Back To Top